Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer

52Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 72 kDa matrix metalloproteinase (MMP-2) and the 92kDa matrix metalloproteinase (MMP-9), are type IV collagenases that have been implicated as important factors in cancer invasion and metastasis formation. We have used quantitative zymography and computer-assisted image analysis to measure the levels of MMP-9 and MMP-2 in 19 samples of serum of lung cancer patients and in 23 samples of normal serum. Mean levels of MMP-9 were significantly elevated in cancer samples compared with normal sera (1.33 ± 0.61 μU μl-1 vs. 0.37 ± 0.10 μU μl-1, P<0.0001). MMP-2 levels did not differ significantly in these two groups. However, there was no significant correlation between serum MMP-9 activity and the disease stage. We found that circulation levels of MMP-9 in lung cancer patients is 3.6-fold higher than in healthy volunteers, however, we do not consider this elevation to be a direct reflection of MMP-9 over-production by tumour cells. © 2001 Harcourt Publishers Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hrabec, E., Strek, M., Nowak, D., & Hrabec, Z. (2001). Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respiratory Medicine, 95(1), 1–4. https://doi.org/10.1053/rmed.2000.0923

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

33%

Biochemistry, Genetics and Molecular Bi... 2

33%

Sports and Recreations 1

17%

Agricultural and Biological Sciences 1

17%

Save time finding and organizing research with Mendeley

Sign up for free